# BioAge Labs Posts $0.73 Q3 GAAP Loss Per Share as Revenue Drops 85.7%

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/51156
Published: 2026-11-07T22:57:43.000Z
Updated: 2026-11-07T22:57:43.000Z
Section: Business

> Revenue was $0.3 million, missing estimates by $1.18 million. Cash, cash equivalents and marketable securities totaled about $352.3 million at Sept. 30.

BioAge Labs posted a $0.73-per-share GAAP loss for the third quarter, missing estimates as revenue fell 85.7% year over year and its quarter-end cash, equivalents and marketable securities totaled about $352.3 million.

Revenue was $0.3 million, $1.18 million below estimates. The per-share loss exceeded estimates by $0.09.

The company had approximately $352.3 million in cash, cash equivalents and marketable securities as of Sept. 30, 2026.